This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Hoffmann La Roche seeks fast FDA approval for saquinavir
Hoffmann La Roche applied to the FDA to market saquinavir, a new AIDS drug attacking HIV replication differently from existing therapies. European trials showed reduced virus levels and higher CD4 counts. FDA spokesman Arthur Whitmore said action could occur in four to six months, with Invirase as the brand name if approved.
MENTIONED IN THIS ARTICLE
Washington
Hoffmann-La Roche Inc
Food and Drug Administration
Hoffmann-La Roche
Nutley
Europe
Arthur Whitmore
FDA
Invirase